One of the major limitations of our meta-analysis is that there were few studies included, and many studies in the literature regarding the diagnosis of primary prostate cancer by 68Ga-PSMA PET/CT were excluded due to lack of effective specific data. This evidence concerns the gene FOLH1 and prostate cancer.